<DOC>
	<DOCNO>NCT02809183</DOCNO>
	<brief_summary>This double-blind , placebo-controlled , parallel-design , 6-arm , fix dose study . The study enroll approximately 130 adult male female subject Stage 3 4 chronic kidney disease low serum bicarbonate level . The study conduct two part . In Part 1 study drug dosing ( TRC101 placebo ) continue 14 day twice daily . In Part 2 study drug dosing ( TRC101 placebo ) continue 14 day daily . The maximum study duration anticipate 42 day .</brief_summary>
	<brief_title>Evaluation TRC101 Subjects With Chronic Kidney Disease Metabolic Acidosis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<criteria>Estimated glomerular filtration rate ( eGFR ) 20 &lt; 60 mL/min/1.73m2 Serum bicarbonate level 12 20 mEq/L Any level low serum bicarbonate , opinion Investigator , require emergency intervention . Severe comorbid condition chronic kidney disease . Chronic obstructive pulmonary disease . Anticipated change dos follow drug drug class : diuretic , nonophthalmic carbonic anhydrase inhibitor , oral diabetes drug , antihypertensive drug , antacid , H2blockers , proton pump inhibitor . Excluded drug drug class : insulin , nondaily `` need '' diuretic , herbal product , dietary supplement , multivitamin , naturopathic remedy , sodium bicarbonate , potassium citrate , sodium citrate alkali therapy , nonsteroidal antiinflammatory drug ( NSAIDs ) , fiber supplement , laxative , calcium magnesium supplement , electrolyte binder binder drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>metabolic acidosis</keyword>
	<keyword>serum bicarbonate</keyword>
	<keyword>kidney disease</keyword>
</DOC>